Aditxt, Inc. (ADTX)
ADTX Stock Price Chart
Explore Aditxt, Inc. interactive price chart. Choose custom timeframes to analyze ADTX price movements and trends.
ADTX Company Profile
Discover essential business fundamentals and corporate details for Aditxt, Inc. (ADTX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
30 Jun 2020
Employees
26.00
Website
https://www.aditxt.comCEO
Amro A. Albanna
Description
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.
ADTX Financial Timeline
Browse a chronological timeline of Aditxt, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 17 Nov 2025
Earnings released on 14 Aug 2025
EPS came in at -$3.45 , while revenue for the quarter reached $1.00K .
Earnings released on 15 May 2025
EPS came in at -$8.12 , while revenue for the quarter reached $1.02K .
Earnings released on 24 Mar 2025
EPS came in at -$100.71 surpassing the estimated -$26.40K by +99.62%, while revenue for the quarter reached $3.18K , missing expectations by -99.25%.
Stock split effective on 17 Mar 2025
Shares were split 1 : 250 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 18 Nov 2024
EPS came in at -$27.77K falling short of the estimated -$27.40K by -1.34%, while revenue for the quarter reached $6.85K , missing expectations by -98.17%.
Stock split effective on 2 Oct 2024
Shares were split 1 : 40 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 19 Aug 2024
EPS came in at -$41.90K falling short of the estimated -$26.90K by -55.76%, while revenue for the quarter reached $44.28K , missing expectations by -87.35%.
Earnings released on 20 May 2024
EPS came in at -$91.40K falling short of the estimated -$33.30K by -174.47%, while revenue for the quarter reached $79.68K , missing expectations by -75.48%.
Earnings released on 2 Apr 2024
EPS came in at -$36.82 falling short of the estimated -$29.81 by -23.52%, while revenue for the quarter reached $81.30K , missing expectations by -40.22%.
Earnings released on 14 Nov 2023
EPS came in at -$487.70K falling short of the estimated -$59.90K by -714.19%, while revenue for the quarter reached $124.49K , missing expectations by -50.21%.
Stock split effective on 18 Aug 2023
Shares were split 1 : 40 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Aug 2023
EPS came in at -$368.00K surpassing the estimated -$1.16M by +68.17%, while revenue for the quarter reached $220.98K , missing expectations by -38.10%.
Earnings released on 15 May 2023
EPS came in at -$1.31 surpassing the estimated -$2.78 by +52.88%, while revenue for the quarter reached $218.42K , missing expectations by -36.32%.
Earnings released on 17 Apr 2023
EPS came in at -$760.24K falling short of the estimated -$1.48 by -51.37M%, while revenue for the quarter reached $185.60K , missing expectations by -46.97%.
Earnings released on 14 Nov 2022
EPS came in at -$2.11M falling short of the estimated -$1.00M by -110.80%, while revenue for the quarter reached $323.13K , missing expectations by -3.40%.
Stock split effective on 14 Sept 2022
Shares were split 1 : 50 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 Aug 2022
EPS came in at -$6.50 falling short of the estimated $5.50 by -218.18%, while revenue for the quarter reached $214.72K , missing expectations by -0.13%.
Earnings released on 16 May 2022
EPS came in at -$7.00 falling short of the estimated $5.50 by -227.27%, while revenue for the quarter reached $210.28K , missing expectations by -97.90%.
Earnings released on 31 Mar 2022
EPS came in at -$15.50 falling short of the estimated $11.50 by -234.78%, while revenue for the quarter reached $105.03K , missing expectations by -98.09%.
Earnings released on 15 Nov 2021
EPS came in at -$20.00 falling short of the estimated $8.50 by -335.29%.
Earnings released on 12 Aug 2021
EPS came in at -$21.00 falling short of the estimated -$2.50 by -740.00%.
Earnings released on 12 May 2021
EPS came in at -$23.00 falling short of the estimated -$10.50 by -119.05%.
Earnings released on 25 Mar 2021
EPS came in at -$22.50 falling short of the estimated -$14.50 by -55.17%.
Earnings released on 13 Nov 2020
EPS came in at -$737.95 falling short of the estimated -$7.98 by -9.15K%.
ADTX Stock Performance
Access detailed ADTX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.